![Property Logo](https://scrape-cdn.mall.adeptmind.ai/assets/_production_assets_blt3ce790f1ab0ba096_hplogo-BzBhLWU1.png)
Home
Biotargets of Cancer in Current Clinical Practice
Barnes and Noble
Biotargets of Cancer in Current Clinical Practice
Current price: $279.99
![Biotargets of Cancer in Current Clinical Practice](https://prodimage.images-bn.com/pimages/9781493959464_p0_v2_s600x595.jpg)
![Biotargets of Cancer in Current Clinical Practice](https://prodimage.images-bn.com/pimages/9781493959464_p0_v2_s600x595.jpg)
Barnes and Noble
Biotargets of Cancer in Current Clinical Practice
Current price: $279.99
Loading Inventory...
Size: OS
Loading Inventory...
presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.